Drug-induced colitis

WikiDoc Resources for Drug-induced colitis
Articles
Most recent articles on Drug-induced colitis Most cited articles on Drug-induced colitis Review articles on Drug-induced colitis Articles on Drug-induced colitis in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Drug-induced colitis Images of Drug-induced colitis Photos of Drug-induced colitis Podcasts & MP3s on Drug-induced colitis Videos on Drug-induced colitis
Evidence Based Medicine
Cochrane Collaboration on Drug-induced colitis Bandolier on Drug-induced colitis TRIP on Drug-induced colitis
Clinical Trials
Ongoing Trials on Drug-induced colitis at Clinical Trials.gov Trial results on Drug-induced colitis Clinical Trials on Drug-induced colitis at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Drug-induced colitis NICE Guidance on Drug-induced colitis NHS PRODIGY Guidance FDA on Drug-induced colitis CDC on Drug-induced colitis
Books
Books on Drug-induced colitis
News
Drug-induced colitis in the news Be alerted to news on Drug-induced colitis News trends on Drug-induced colitis
Commentary
Blogs on Drug-induced colitis
Definitions
Definitions of Drug-induced colitis
Patient Resources / Community
Patient resources on Drug-induced colitis Discussion groups on Drug-induced colitis Patient Handouts on Drug-induced colitis Directions to Hospitals Treating Drug-induced colitis Risk calculators and risk factors for Drug-induced colitis
Healthcare Provider Resources
Symptoms of Drug-induced colitis Causes & Risk Factors for Drug-induced colitis Diagnostic studies for Drug-induced colitis Treatment of Drug-induced colitis
Continuing Medical Education (CME)
CME Programs on Drug-induced colitis
International
Drug-induced colitis en Espanol Drug-induced colitis en Francais
Business
Drug-induced colitis in the Marketplace Patents on Drug-induced colitis
Experimental / Informatics
List of terms related to Drug-induced colitis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Qasim Salau, M.B.B.S., FMCPaed [2]

Synonyms and keywords: Drug-related colitis, Drug-induced enterocolitis, Non-steroidal anti-inflammatory drug (NSAID) induced colitis; Chemotherapeutic drug-induced colitis

Historical Perspective

• [Disease name] was first discovered by [scientist name], a [nationality + occupation], in [year] during/following [event].
• In [year], [gene] mutations were first identified in the pathogenesis of [disease name].
• In [year], the first [discovery] was developed by [scientist] to treat/diagnose [disease name].

Classification

• There is no established classification method for drug-induced colitis. However, it may be classified based on the type of drug, pathophysiologic pattern and duration of symptoms.

Classification based on pathophysiologic pattern

Pathophysiologic pattern of colitis	Drugs
Focal active colitis	NSAIDs, sodium phosphate (oral)
Eosinophilic colitis	NSAIDs, carbamazepine, antiplatelet drugs, estrogen, progesteron, gold
Ischemic colitis	NSAIDs, digoxin, diuretics, cocaine, ergotamine, sumatriptan, amphetamines, glutaraldehyde, antibiotics, chemotherapy drugs, constipation-inducing medications, laxatives, vasopressor agents, estrogen, progesteron, mycophenolic acid
Microscopic colitis	NSAIDs, Protein pump inhibitors (lansoprazole), H2 receptor blockers (e.g. ranitidine), ticlopidine, simvastatin, carbamazepine, sertraline, oral penicillin
Pseudomembranous colitis	NSAIDs, antibiotic-associated Clostridium difficile colitis (e.g. penicillins, clindamycin, cephalosporins, fluoroquinolones)
Apoptotic colitis	NSAIDs, oral sodium phosphate, laxatives, chemotherapy drugs (especially anti-metabolites), and cyclosporine A
Neutropenic colitis	Chemotherapy drugs
Immune-mediated colitis	CTLA4 antibodies

Classification based on type of drugs

Drug-induced colitis can be classified based on the type of drugs into:

• Non-steroidal anti-inflammatory drugs (NSAID)-induced colitis
• Chemotherapeutic-drugs induced colitis
• Clostridium difficile colitis

Pathophysiology

• The pathogenesis of [disease name] is characterized by [feature1], [feature2], and [feature3].
• The [gene name] gene/Mutation in [gene name] has been associated with the development of [disease name], involving the [molecular pathway] pathway.
• On gross pathology, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].
• On microscopic histopathological analysis, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].

Causes

• [Disease name] may be caused by either [cause1], [cause2], or [cause3].
• [Disease name] is caused by a mutation in the [gene1], [gene2], or [gene3] gene[s].
• There are no established causes for [disease name].

Differentiating [disease name] from other Diseases

• [Disease name] must be differentiated from other diseases that cause [clinical feature 1], [clinical feature 2], and [clinical feature 3], such as:

• [Differential dx1]
• [Differential dx2]
• [Differential dx3]

Epidemiology and Demographics

• The prevalence of [disease name] is approximately [number or range] per 100,000 individuals worldwide.
• In [year], the incidence of [disease name] was estimated to be [number or range] cases per 100,000 individuals in [location].

Age

• Patients of all age groups may develop [disease name].

• [Disease name] is more commonly observed among patients aged [age range] years old.
• [Disease name] is more commonly observed among [elderly patients/young patients/children].

Gender

• [Disease name] affects men and women equally.

• [Gender 1] are more commonly affected with [disease name] than [gender 2].
• The [gender 1] to [Gender 2] ratio is approximately [number > 1] to 1.

Race

• There is no racial predilection for [disease name].

• [Disease name] usually affects individuals of the [race 1] race.
• [Race 2] individuals are less likely to develop [disease name].

Risk Factors

• Common risk factors in the development of [disease name] are [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].

Natural History, Complications and Prognosis

• The majority of patients with [disease name] remain asymptomatic for [duration/years].
• Early clinical features include [manifestation 1], [manifestation 2], and [manifestation 3].
• If left untreated, [#%] of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
• Common complications of [disease name] include [complication 1], [complication 2], and [complication 3].
• Prognosis is generally [excellent/good/poor], and the [1/5/10­year mortality/survival rate] of patients with [disease name] is approximately [#%].

Diagnosis

Diagnostic Criteria

• The diagnosis of [disease name] is made when at least [number] of the following [number] diagnostic criteria are met:

• [criterion 1]
• [criterion 2]
• [criterion 3]
• [criterion 4]

Symptoms

• [Disease name] is usually asymptomatic.
• Symptoms of [disease name] may include the following:

• [symptom 1]
• [symptom 2]
• [symptom 3]
• [symptom 4]
• [symptom 5]
• [symptom 6]

Physical Examination

• Patients with [disease name] usually appear [general appearance].
• Physical examination may be remarkable for:

• [finding 1]
• [finding 2]
• [finding 3]
• [finding 4]
• [finding 5]
• [finding 6]

Laboratory Findings

• There are no specific laboratory findings associated with [disease name].

• A [positive/negative] [test name] is diagnostic of [disease name].
• An [elevated/reduced] concentration of [serum/blood/urinary/CSF/other] [lab test] is diagnostic of [disease name].
• Other laboratory findings consistent with the diagnosis of [disease name] include [abnormal test 1], [abnormal test 2], and [abnormal test 3].

Imaging Findings

• There are no [imaging study] findings associated with [disease name].

• [Imaging study 1] is the imaging modality of choice for [disease name].
• On [imaging study 1], [disease name] is characterized by [finding 1], [finding 2], and [finding 3].
• [Imaging study 2] may demonstrate [finding 1], [finding 2], and [finding 3].

Other Diagnostic Studies

• [Disease name] may also be diagnosed using [diagnostic study name].
• Findings on [diagnostic study name] include [finding 1], [finding 2], and [finding 3].

Treatment

Medical Therapy

• There is no treatment for [disease name]; the mainstay of therapy is supportive care.

• The mainstay of therapy for [disease name] is [medical therapy 1] and [medical therapy 2].
• [Medical therapy 1] acts by [mechanism of action 1].
• Response to [medical therapy 1] can be monitored with [test/physical finding/imaging] every [frequency/duration].

Surgery

• Surgery is the mainstay of therapy for [disease name].
• [Surgical procedure] in conjunction with [chemotherapy/radiation] is the most common approach to the treatment of [disease name].
• [Surgical procedure] can only be performed for patients with [disease stage] [disease name].

Prevention

• There are no primary preventive measures available for [disease name].

• Effective measures for the primary prevention of [disease name] include [measure1], [measure2], and [measure3].

• Once diagnosed and successfully treated, patients with [disease name] are followed-up every [duration]. Follow-up testing includes [test 1], [test 2], and [test 3].